Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Clinical Trials Site Director
Lovelace Respiratory Research Institute - Albuquerque, NM
Scientist/Sr. Scientist, Bio-analytical Chemistry
Dicerna Pharmaceuticals, Inc. - Watertown, MA
Laboratory Facility Manager
International AIDS Vaccine Initiative - New York, NY
Patient Support Specialist Job
Celgene Corporation - Berkeley Heights, NJ, US
Clinical Research Coordinator
Lovelace Respiratory Research Institute - Albuquerque, NM

More Jobs >>

Events

New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
Enforcement, Litigation and Compliance Conference
Dec. 6-7 — Washington, DC
Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia
CHI's Summit for Clinical Ops Executives (Scope)
February 7-9 — Miami

More Events >>

COPD News

Most Popular COPD Story

Oral vax provides big assist to patients with severe COPD

April 14, 2010 — 3:48pm ET | By John Carroll

An experimental oral vaccine built with the bacteria that triggers childhood meningitis significantly reduced the level and severity of chronic obstructive pulmonary disorder flare-ups in a small Read more...

COPD Press Releases

Nature's Bioceuticals Enters Chronic Obstructive Pulmonary Disease Market After Acquiring Breakthrough Breathing Formula
Panmira Announces Appointment of New CEO
Pulmatrix Secures a $14 million Financing to Advance Clinical Programs in COPD and Cystic Fibrosis
Pulmatrix Invests in Clinical Programs in COPD and Cystic Fibrosis
Pulmatrix Secures a $14 million Financing to Advance Clinical Programs in COPD and Cystic Fibrosis

Latest Headlines

Oral vax provides big assist to patients with severe COPD
April 14, 2010

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK